Blocking of ERK1 and ERK2 sensitizes human mesothelioma cells to doxorubicin

BACKGROUND: Malignant mesotheliomas (MM) have a poor prognosis, largely because of their chemoresistance to anti-cancer drugs such as doxorubicin (Dox). Here we show using human MM lines that Dox activates extracellular signal-regulated kinases (ERK1 and 2), causally linked to increased expression o...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Shukla, Arti, Hillegass, Jedd M, MacPherson, Maximilian B, Beuschel, Stacie L, Vacek, Pamela M, Pass, Harvey I, Carbone, Michele, Testa, Joseph R, Mossman, Brooke T
Formato: Artigo
Idioma:Inglês
Publicado: BioMed Central 2010
Assuntos:
Research
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC3016286/
https://ncbi.nlm.nih.gov/pubmed/21159167
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1476-4598-9-314
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares